AntineoplasticsDrug resistance: 8 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1807卷 / 1期

关键词：

D O I：

10.1007/s40278-020-79311-4

中图分类号：

学科分类号：

摘要：

引用

下载

收藏

页码：25 / 25

相关论文

共 50 条

[21] AntineoplasticsDrug eruption in the form of various toxicities: 22 case reports
Reactions Weekly, 2025, 2052 (1) : 45 - 45
[22] AntineoplasticsDrug resistance, fatigue and lack of efficacy: case report
Reactions Weekly, 2023, 1966 (1) : 49 - 49
[23] AntineoplasticsDrug resistance secondary to acquired gene mutation: case report
Reactions Weekly, 2019, 1739 (1) : 36 - 36
[24] AntineoplasticsAcquired resistance and no response: 8 case reports
Reactions Weekly, 2022, 1921 (1) : 33 - 33
[25] OsimertinibDrug-resistance: 8 case reports
Reactions Weekly, 2024, 2033 (1) : 227 - 227
[26] AntiretroviralsAcquired drug resistance: 8 case reports
Reactions Weekly, 2021, 1855 (1) : 57 - 57
[27] Afatinib/bevacizumabAcquired resistance: 8 case reports
Reactions Weekly, 2018, 1726 (1) : 20 - 20
[28] LinezolidEmergence of drug resistance: 8 case reports
Reactions Weekly, 2020, 1785 (1) : 316 - 316
[29] AntineoplasticsDrug resistance, lack of efficacy and myositis: case report
Reactions Weekly, 2023, 1944 (1) : 79 - 79
[30] AntineoplasticsDrug resistance to osimertinib and savolitinib and diarrhoea: case report
Reactions Weekly, 2017, 1643 (1) : 30 - 30

← 1 2 3 4 5 →